JPH07252255A - 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt - Google Patents

5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt

Info

Publication number
JPH07252255A
JPH07252255A JP7037649A JP3764995A JPH07252255A JP H07252255 A JPH07252255 A JP H07252255A JP 7037649 A JP7037649 A JP 7037649A JP 3764995 A JP3764995 A JP 3764995A JP H07252255 A JPH07252255 A JP H07252255A
Authority
JP
Japan
Prior art keywords
group
compound
naphthyridine
tetrahydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7037649A
Other languages
Japanese (ja)
Inventor
Kazunori Oono
一教 大野
Osamu Odai
修 小田井
Yukio Tominaga
幸雄 冨永
Kiyoshi Furukawa
清 古川
Makoto Oka
眞 岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP7037649A priority Critical patent/JPH07252255A/en
Publication of JPH07252255A publication Critical patent/JPH07252255A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain the subject compound useful as a synthetic intermediate for a medicine, especially benzodiazepine receptor such as an antianxiety agent, an antiepileptic or a therapeutic agent for sleeping disorder. CONSTITUTION:This new compound is 5,6,7,8-tetrahydro-2(2h)-oxo-1,6- naphthyridine-3-carboxyic acid of formula I [R1 is H, an acyl, a lower alkyl or R1' CH2 (R1' is a cyclo lower alkyl, a lower alkyl, etc.); R is H, a lower alkyl or benzyl; with the proviso that R1 is not methyl] or its salt such as 6-benzy1-5, 6, 7, 8-tetrahydro-2(1H)-oxo-1,6-naphthyridine-3-naphthyridine-3- carboxylic acid. The compound of formula I, for example, is obtained by reacting a compound of formula II ((n) is 1-3 integer) with a compound of formula III (Y is a halogen, etc.; Z is cyano, etc.; R is lower alkyl or benzyl) in a solvent such as methanol at 0-120 deg.C.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は医薬、特に、ベンゾジア
ゼピン受容体作動薬として有用な3−(1,3,4−オ
キサジアゾール−2−イル)−5,6,7,8−テトラ
ヒドロ−1,6−ナフチリジン−2(1H)−オン誘導
体の製造中間体に関する。更に詳しくは、新規5,6,
7,8−テトラヒドロ−2(1H)−オキソ−1,6−
ナフチリジン−3−カルボン酸誘導体またはその塩に関
する。
FIELD OF THE INVENTION The present invention relates to pharmaceuticals, particularly 3- (1,3,4-oxadiazol-2-yl) -5,6,7,8-tetrahydro-, which is useful as a benzodiazepine receptor agonist. It relates to an intermediate for producing a 1,6-naphthyridine-2 (1H) -one derivative. More specifically, the new 5,6
7,8-Tetrahydro-2 (1H) -oxo-1,6-
It relates to a naphthyridine-3-carboxylic acid derivative or a salt thereof.

【0002】[0002]

【従来技術および発明が解決しようとする課題】Arkiv
foer Kemi 26 (41), 489-495 (1967)〔ケミカル アブ
ストラクト第67巻第32611z頁(1967年)〕
には下記式
2. Description of the Related Art Arkiv
foer Kemi 26 (41), 489-495 (1967) [Chemical Abstracts Vol. 67, 32611z (1967)]
The following formula

【0003】[0003]

【化2】 で示される化合物が記載されている。本発明の化合物に
ついてはいまだ全く報告されていない。
[Chemical 2] Compounds represented by are described. No compound of the present invention has been reported yet.

【0004】本発明は医薬として有用な、特に、ベンゾ
ジアゼピン受容体に親和性を有する3−(1,3,4−
オキサジアゾール−2−イル)−5,6,7,8−テト
ラヒドロ−1,6−ナフチリジン−2(1H)−オン誘
導体の製造中間体を提供することにある。更に詳しく
は、新規5,6,7,8−テトラヒドロ−2(1H)−
オキソ−1,6−ナフチリジン−3−カルボン酸誘導体
またはその塩を提供することにある。
The present invention is useful as a medicine, especially 3- (1,3,4-) having an affinity for benzodiazepine receptors.
It is intended to provide an intermediate for producing an oxadiazol-2-yl) -5,6,7,8-tetrahydro-1,6-naphthyridin-2 (1H) -one derivative. More specifically, novel 5,6,7,8-tetrahydro-2 (1H)-
It is intended to provide an oxo-1,6-naphthyridine-3-carboxylic acid derivative or a salt thereof.

【0005】[0005]

【課題を解決するための手段】本発明は下記式(I)The present invention provides the following formula (I)

【0006】[0006]

【化3】 [Chemical 3]

【0007】(式中、R1 は水素原子,アシル基,低級
アルキル基またはR1'CH2-を意味し、R1'はシクロ低
級アルキル基, 低級アルケニル基, 低級アルキニル基,
ベンジル基, アリール基または芳香族複素環基を意味
し、Rは水素原子,低級アルキル基またはベンジル基を
意味する。但し、R1 はメチル基でない。)で表される
5,6,7,8−テトラヒドロ−2(1H)−1,6−
ナフチリジン−3−カルボン酸誘導体またはその塩に関
する。
(Wherein R 1 represents a hydrogen atom, an acyl group, a lower alkyl group or R 1 'CH 2- , and R 1 ' is a cyclo lower alkyl group, a lower alkenyl group, a lower alkynyl group,
It means a benzyl group, an aryl group or an aromatic heterocyclic group, and R means a hydrogen atom, a lower alkyl group or a benzyl group. However, R 1 is not a methyl group. ) 5,6,7,8-tetrahydro-2 (1H) -1,6-
It relates to a naphthyridine-3-carboxylic acid derivative or a salt thereof.

【0008】本発明の化合物は上記式(I) で示される
が、好ましい化合物は式(I) においてR1 がR1'CH2-
であって、R1'がアリール基または芳香族複素環基であ
り、特に好ましい化合物はR1'がフェニル基または1乃
至2個のハロゲン原子で置換されたフェニル基の化合物
である。
The compounds of the present invention are represented by the above formula (I), and preferred compounds are those of the formula (I) in which R 1 is R 1 'CH 2-.
Wherein R 1 ′ is an aryl group or an aromatic heterocyclic group, and a particularly preferred compound is a compound in which R 1 ′ is a phenyl group or a phenyl group substituted with 1 to 2 halogen atoms.

【0009】本発明の化合物(I) は酸と塩を形成しても
よく、塩としては、例えば塩酸塩,臭化水素酸塩,ヨウ
化水素酸塩,硫酸塩,リン酸塩等の無機酸塩、酢酸塩,
シュウ酸塩,マレイン酸塩,フマル酸塩,マロン酸塩,
乳酸塩,リンゴ酸塩,クエン酸塩,酒石酸塩,安息香酸
塩,メタンスルホン酸塩,トシル酸塩等の有機酸塩が挙
げられる。また、式(I) においてRが水素原子である本
発明の化合物(I) は塩基と塩を形成してもよく、塩とし
ては、例えば水酸化アルカリ,炭酸アルカリ等とのアル
カリ塩、ピリジン,トリエチルアミン,トリブチルアミ
ン等の有機塩基との塩が挙げられる。
The compound (I) of the present invention may form a salt with an acid, and examples of the salt include inorganic salts such as hydrochloride, hydrobromide, hydroiodide, sulfate and phosphate. Acid salt, acetate,
Oxalate, maleate, fumarate, malonate,
Examples thereof include organic acid salts such as lactate, malate, citrate, tartrate, benzoate, methanesulfonate, tosylate. Further, the compound (I) of the present invention in which R is a hydrogen atom in the formula (I) may form a salt with a base, and examples of the salt include alkali salts with alkali hydroxide, alkali carbonate, pyridine, Examples thereof include salts with organic bases such as triethylamine and tributylamine.

【0010】本明細書において、「低級」とは炭素数1
〜6個の直鎖状または分岐状からなると同義である。ア
シル基とは低級アルカノイル基,ベンゾイル基,ナフト
イル基等を意味する。「アリール基」とはフェニル基,
ナフチル基等を意味し、その環は置換基を有していても
よい。その環の好ましい置換基としてはハロゲン原子,
低級アルキル,トリフルオロメチル,水酸基,低級アル
コキシ,ニトロ基が挙げられる。また、芳香族複素環基
としては例えば、チエニル,フリル,ピリジニル,イソ
キサゾリル等ヘテロ原子を1〜2個含む5〜6員環が挙
げられ、その環は置換基を有していてもよい。「ヘテロ
原子」とは窒素原子,酸素原子,硫黄原子を意味する。
その環の好ましい置換基としてはハロゲン原子,低級ア
ルキル,トリフルオロメチル,低級アルコキシ基が挙げ
られる。
In the present specification, "lower" has 1 carbon atom.
It is synonymous with consisting of 6 linear or branched. The acyl group means a lower alkanoyl group, a benzoyl group, a naphthoyl group and the like. The "aryl group" means a phenyl group,
It means a naphthyl group or the like, and the ring may have a substituent. Preferred substituents on the ring are halogen atoms,
Examples include lower alkyl, trifluoromethyl, hydroxyl group, lower alkoxy, and nitro group. In addition, examples of the aromatic heterocyclic group include 5- to 6-membered rings containing 1 to 2 heteroatoms such as thienyl, furyl, pyridinyl and isoxazolyl, and the ring may have a substituent. "Hetero atom" means a nitrogen atom, an oxygen atom, and a sulfur atom.
Preferable substituents on the ring include halogen atom, lower alkyl, trifluoromethyl and lower alkoxy group.

【0011】本発明の化合物は以下の方法により製造す
ることができる。
The compound of the present invention can be produced by the following method.

【0012】(製造法1)式(I)で表されるある種の
後記化合物(6および7)は、 Arkiv foer Kemi26 (4
1), 489-495 (1967)〔ケミカル アブストラクト第67
巻第32611z頁(1967年)〕に記載の方法に準
じて、あるいは下記反応式(化4)に示される方法によ
り製造することができる。
(Production Method 1) Certain of the following compounds (6 and 7) represented by the formula (I) are Arkiv foer Kemi26 (4
1), 489-495 (1967) [Chemical Abstract No. 67
Vol. 32611z page (1967)] or by the method represented by the following reaction formula (Formula 4).

【0013】[0013]

【化4】 [Chemical 4]

【0014】(反応式中、Yはハロゲン原子,低級アル
コキシ基またはジ低級アルキルアミノ基を意味し、Zは
シアノ基,低級アルコキシカルボニル基またはベンジル
オキシカルボニル基を意味し、Rは低級アルキル基また
はベンジル基を意味し、nは整数1〜3を意味し、R1
は前掲に同じ。)
(In the reaction formula, Y represents a halogen atom, a lower alkoxy group or a di-lower alkylamino group, Z represents a cyano group, a lower alkoxycarbonyl group or a benzyloxycarbonyl group, and R represents a lower alkyl group or A benzyl group, n means an integer of 1 to 3, R 1
Is the same as above. )

【0015】上記反応において出発原料として用いる化
合物(1)は、例えば、ジャーナルオブ アメリカン
ケミカル ソサイアティ(Journal of American Chemic
al Society)第85巻第207頁(1963年)に記載
の方法に準じて製造することができる。この様にして製
造した化合物(1)と化合物(2)をメタノール,エタ
ノールの如きアルコール類、テトラヒドロフラン,ジオ
キサンの如きエーテル類、ベンゼン,トルエンの如き芳
香族炭化水素類等の溶媒中通常0〜120℃で反応させ
ることにより化合物(3)とし、次いで、アンモニアも
しくは酢酸アンモニウムの如きアンモニウム塩をメタノ
ール,エタノールの如きアルコール類、テトラヒドロフ
ラン,ジオキサンの如きエーテル類、アセトニトリル等
の溶媒中通常0〜100℃で反応させることにより化合
物(4)を得ることができる。
The compound (1) used as the starting material in the above reaction is, for example, Journal of American
Chemical Society (Journal of American Chemic
al Society) Vol. 85, p. 207 (1963). The compound (1) and the compound (2) thus produced are usually used in a solvent such as alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and dioxane, aromatic hydrocarbons such as benzene and toluene, and the like, usually 0 to 120. A compound (3) is obtained by reacting at 0 ° C., and then ammonium salt such as ammonia or ammonium acetate is usually added at 0-100 ° C. in a solvent such as alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and dioxane, acetonitrile and the like. Compound (4) can be obtained by reacting.

【0016】化合物(4)においてZがシアノ基である
ときは、化合物(4)を塩基の存在下にメタノール,エ
タノールの如きアルコール類、テトラヒドロフラン,ジ
オキサンの如きエーテル類等の溶媒中通常0〜100℃
で処理することにより化合物(5)とし、次いで、5〜
10%塩酸あるいは5〜20%硫酸水溶液等の酸性条件
下亜硝酸ナトリウムと通常0〜20℃で反応させること
により化合物(6)を得ることができる。
When Z is a cyano group in the compound (4), the compound (4) is usually used in the presence of a base in a solvent such as alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and dioxane, and the like, usually 0 to 100. ℃
To give compound (5), and then 5 to
Compound (6) can be obtained by reacting with sodium nitrite under acidic conditions such as 10% hydrochloric acid or 5-20% sulfuric acid aqueous solution at 0-20 ° C.

【0017】また、化合物(4)においてZが低級アル
コキシカルボニル基またはベンジルオキシカルボニル基
であるときは、化合物(4)をメタノール,エタノール
の如きアルコール類、テトラヒドロフラン,ジオキサン
の如きエーテル類、アセトニトリル等の溶媒中通常50
〜120℃で加熱することにより、化合物(6)を得る
ことができる。
When Z is a lower alkoxycarbonyl group or a benzyloxycarbonyl group in the compound (4), the compound (4) is treated with an alcohol such as methanol or ethanol, an ether such as tetrahydrofuran or dioxane, an acetonitrile or the like. Usually 50 in solvent
A compound (6) can be obtained by heating at -120 degreeC.

【0018】次に、化合物(6)を酸性あるいはアルカ
リ性条件下通常の方法により加水分解することにより、
または、通常の方法により水素雰囲気下で加水素分解す
ることにより化合物(7)を得ることができる。
Next, the compound (6) is hydrolyzed by an ordinary method under acidic or alkaline conditions,
Alternatively, the compound (7) can be obtained by hydrogenolysis under a hydrogen atmosphere by a usual method.

【0019】(製造法2)また、式(I)で表されるあ
る種の後記化合物(10) は、下記反応式(化5)に示さ
れる方法によっても製造できる。
(Production Method 2) Further, a certain compound (10) described below represented by the formula (I) can also be produced by the method represented by the following reaction formula (Formula 5).

【0020】[0020]

【化5】 [Chemical 5]

【0021】(反応式中、R" は低級アルキル基,ベン
ジル基,低級アルコキシカルボニル基またはベンジルオ
キシカルボニル基を意味し、R''' は水素原子およびア
シル基以外のR1 と同じ基を意味し、Rは前掲に同
じ。)
(In the reaction formula, R "means a lower alkyl group, a benzyl group, a lower alkoxycarbonyl group or a benzyloxycarbonyl group, and R"'means the same group as R 1 other than a hydrogen atom and an acyl group. However, R is the same as above.)

【0022】化合物(8)の置換基R" と化合物(10)
の置換基R''' は化合物(9)を介して相互に変換でき
る。化合物(8)においてR" が低級アルキル基または
ベンジル基であるときは、例えば、ジャーナル オブ
オルガニック ケミストリー(Journal of Organic Che
mistry)第49巻第2081頁(1984年)に記載の
方法に準じて、化合物(8)をクロロ炭酸1−クロロエ
チル等で処理することにより化合物(9)を得ることが
できる。
The substituent R "of the compound (8) and the compound (10)
The substituents R ″ ′ of can be mutually converted via the compound (9). When R ″ in the compound (8) is a lower alkyl group or a benzyl group, for example, Journal of
Organic Chemistry (Journal of Organic Che
mistry) According to the method described in Vol. 49, p. 2081 (1984), compound (9) can be obtained by treating compound (8) with 1-chloroethyl chlorocarbonate or the like.

【0023】化合物(8)においてR" がベンジル基ま
たはベンジルオキシカルボニル基であるときは、水,メ
タノール,エタノール,酢酸,ジオキサン,酢酸エチル
等の溶媒中通常25〜80℃で、常圧または加圧下にラ
ネーニッケル,パラジウム−炭素等の触媒の存在下に水
素と反応させることにより化合物(9)を得ることがで
きる。
When R "in the compound (8) is a benzyl group or a benzyloxycarbonyl group, it is usually in a solvent such as water, methanol, ethanol, acetic acid, dioxane or ethyl acetate at 25 to 80 ° C. under normal pressure or pressure. Compound (9) can be obtained by reacting with hydrogen under pressure in the presence of a catalyst such as Raney nickel or palladium-carbon.

【0024】また、R" が低級アルコキシカルボニル基
またはベンジルオキシカルボニル基であるときは、適当
な溶媒中酸または塩基で処理することにより化合物
(9)を得ることができる。例えば、R" がtert−
ブトキシカルボニル基であるときは、ジクロルメタン,
クロロホルム等の溶媒中通常25〜80℃でトリフルオ
ロ酢酸で処理することにより化合物(9)を得ることが
できる。
When R "is a lower alkoxycarbonyl group or a benzyloxycarbonyl group, compound (9) can be obtained by treating with acid or base in a suitable solvent. For example, R" is tert. −
When it is a butoxycarbonyl group, dichloromethane,
Compound (9) can be obtained by treating with trifluoroacetic acid in a solvent such as chloroform at 25 to 80 ° C.

【0025】次いで、化合物(9)とR''' に対応する
アルキル化剤、例えば低級アルキル,アリル, プロパギ
ル, ベンジル,ナフタレンメチル,芳香族複素環メチル
化剤とを水酸化アルカリ(例えば、水酸化ナトリウム,
水酸化カリウム),炭酸アルカリ(例えば、炭酸ナトリ
ウム,炭酸カリウム),重炭酸アルカリ(例えば、重炭
酸ナトリウム,重炭酸カリウム)の如き無機塩基、また
は、ピリジン,トリエチルアミン,トリブチルアミンの
如き有機塩基の存在下、アセトン,メチルエチルケト
ン,ジエチルケトン,ジメチルホルムアミド,ベンゼ
ン,トルエン,アセトニトリル等の溶媒中通常25〜1
00℃で反応させることにより化合物(10)に導くこと
ができる。これらのアルキル化剤は通常使用されるもの
でよく、例えばハロゲン化アルキルが挙げられる。
Then, the compound (9) and an alkylating agent corresponding to R ''', for example, lower alkyl, allyl, propargyl, benzyl, naphthalenemethyl, and an aromatic heterocyclic methylating agent are treated with an alkali hydroxide (for example, water). Sodium oxide,
Presence of inorganic bases such as potassium hydroxide), alkali carbonates (eg sodium carbonate, potassium carbonate), alkali bicarbonates (eg sodium bicarbonate, potassium bicarbonate) or organic bases such as pyridine, triethylamine, tributylamine Under a solvent such as acetone, methyl ethyl ketone, diethyl ketone, dimethylformamide, benzene, toluene and acetonitrile, usually 25 to 1
The compound (10) can be obtained by reacting at 00 ° C. These alkylating agents may be those usually used, and examples thereof include alkyl halides.

【0026】(製造法3)また、式(I)で表されるあ
る種の後記化合物(14) は、下記反応式(化6)に示さ
れる方法によっても製造できる。
(Production Method 3) Also, a certain compound (14) described below represented by the formula (I) can be produced by the method represented by the following reaction formula (Formula 6).

【0027】[0027]

【化6】 [Chemical 6]

【0028】(反応式中、R" は低級アルキル基,ベン
ジル基またはtert−ブトキシカルボニル基を意味
し、Xはハロゲン原子を意味し、R''' は水素原子およ
びアシル基以外のR1 と同じ基を意味し、Rは前掲に同
じ。)
(In the reaction formula, R "represents a lower alkyl group, a benzyl group or a tert-butoxycarbonyl group, X represents a halogen atom, and R"'represents a hydrogen atom and R 1 other than an acyl group. Means the same group, and R is the same as the above.)

【0029】化合物(8)とハロゲン化剤、例えばハロ
ゲン化リン, オキシハロゲン化リン,二ハロゲン化フェ
ニルホスホン酸を無溶媒または適当な溶媒中、通常25〜
180℃で反応させ化合物(11)とし、次いで、化合物(1
1)においてR" が低級アルキル基またはベンジル基で
あるときは、例えば、ジャーナル オブ オルガニック
ケミストリー(Journal of Organic Chemistry)第4
9巻第2081頁(1984年)に記載の方法に準じ
て、化合物(11)をクロロ炭酸1−クロロエチル等で処
理することにより化合物(12)を得ることができる。
The compound (8) and a halogenating agent such as phosphorus halide, phosphorus oxyhalogenate, and dihalogenated phenylphosphonic acid are used in the absence of solvent or in a suitable solvent, usually 25 to
The compound (11) is reacted at 180 ° C, and then the compound (1
When R "in 1) is a lower alkyl group or a benzyl group, for example, Journal of Organic Chemistry No. 4
The compound (12) can be obtained by treating the compound (11) with 1-chloroethyl chlorocarbonate or the like according to the method described in Vol. 9, page 2081 (1984).

【0030】また、化合物(11)においてR" がter
t−ブトキシカルボニル基であるときは、化合物(11)
をジクロルメタン,クロロホルム等の溶媒中通常25〜
80℃でトリフルオロ酢酸で処理することにより化合物
(12)を得ることができる。
In the compound (11), R "is ter.
When it is a t-butoxycarbonyl group, the compound (11)
In a solvent such as dichloromethane, chloroform, etc.
Compound (12) can be obtained by treating with trifluoroacetic acid at 80 ° C.

【0031】上記で得られた化合物(12)とR''' に対
応するアルキル化剤、例えば低級アルキル,アリル, プ
ロパギル, ベンジル,ナフタレンメチル,芳香族複素環
メチル化剤とを水酸化アルカリ(例えば、水酸化ナトリ
ウム,水酸化カリウム),炭酸アルカリ(例えば、炭酸
ナトリウム,炭酸カリウム),重炭酸アルカリ(例え
ば、重炭酸ナトリウム,重炭酸カリウム)の如き無機塩
基、または、ピリジン,トリエチルアミン,トリブチル
アミンの如き有機塩基の存在下、アセトン,メチルエチ
ルケトン,ジエチルケトン,ジメチルホルムアミド,ベ
ンゼン,トルエン,アセトニトリル等の溶媒中通常25
〜100℃で反応させることにより化合物(13)を得る
ことができる。これらのアルキル化剤は通常使用される
ものでよく、例えばハロゲン化アルキルが挙げられる。
The compound (12) obtained above and an alkylating agent corresponding to R ''', such as lower alkyl, allyl, propargyl, benzyl, naphthalenemethyl, and an aromatic heterocyclic methylating agent are treated with an alkali hydroxide ( For example, inorganic bases such as sodium hydroxide, potassium hydroxide), alkali carbonates (eg sodium carbonate, potassium carbonate), alkali bicarbonates (eg sodium bicarbonate, potassium bicarbonate), or pyridine, triethylamine, tributylamine. In the presence of organic bases such as acetone, methyl ethyl ketone, diethyl ketone, dimethylformamide, benzene, toluene, acetonitrile, etc.
Compound (13) can be obtained by reacting at -100 ° C. These alkylating agents may be those usually used, and examples thereof include alkyl halides.

【0032】次いで、化合物(13)を酸性あるいはアル
カリ性条件下通常の方法により加水分解することによ
り、化合物(14)に導くことができる。
Then, the compound (13) can be converted into the compound (14) by hydrolyzing the compound (13) under acidic or alkaline conditions by a conventional method.

【0033】かくして製造される式(I)で表される化
合物は下記反応式(化7)に従って、医薬特に、ベンゾ
ジアゼピン受容体作動薬として有用な3−(1,3,4
−オキサジアゾール−2−イル)−5,6,7,8−テ
トラヒドロ−1,6−ナフチリジン−2(1H)−オン
誘導体に導くことができる。
The compound represented by the formula (I) thus produced is useful in medicine, especially as a benzodiazepine receptor agonist 3- (1, 3, 4) according to the following reaction formula (Chem. 7).
-Oxadiazol-2-yl) -5,6,7,8-tetrahydro-1,6-naphthyridin-2 (1H) -one derivative.

【0034】[0034]

【化7】 [Chemical 7]

【0035】(反応式中、Rは水素原子,低級アルキル
基など、R2 は低級アルキル基,低級アルコキシ基など
であり、R1 は前掲に同じ。)
(In the reaction formula, R is a hydrogen atom, a lower alkyl group or the like, R 2 is a lower alkyl group, a lower alkoxy group or the like, and R 1 is the same as the above.)

【0036】すなわち、化合物(I) から化合物(III) の
製造は、化合物(I) またはそのカルボキシル基における
反応性誘導体とH2NNHCOR2 (R2 は前掲に同
じ。)で表されるヒドラジドとを、通常のアミド化反応
条件下に反応させ化合物(II)とし、あるいは、化合物
(I) またはそのカルボキシル基における反応性誘導体と
ヒドラジンとを通常のアミド化反応条件下に反応させ、
次いで、R2 COOH(R2 は前掲に同じ。)で表され
るカルボキシル基における反応性誘導体と反応させる2
段階反応で化合物(II)とし、次いで、上記で得られた化
合物(II)を分子内で脱水閉環させることにより行うこと
ができる。
That is, the compound (III) is produced from the compound (I) by reacting the compound (I) or its reactive derivative at the carboxyl group with the hydrazide represented by H 2 NNHCOR 2 (R 2 is the same as the above). Is reacted under ordinary amidation reaction conditions to give compound (II), or
(I) or a reactive derivative of the carboxyl group and hydrazine are reacted under normal amidation reaction conditions,
Then, it is reacted with a reactive derivative at the carboxyl group represented by R 2 COOH (R 2 is the same as above) 2
Compound (II) can be obtained by stepwise reaction, and then compound (II) obtained above can be dehydrated and ring-closed in the molecule.

【0037】[0037]

【実施例】以下に参考例および実施例を挙げて、本発明
の化合物について具体的に説明する。
EXAMPLES The compounds of the present invention will be specifically described with reference to the following Reference Examples and Examples.

【0038】実施例1: 6−ベンジル−5,6,7,8−テトラヒドロ−2(1
H)−オキソ−1,6−ナフチリジン−3−カルボン酸
エチル:
Example 1 : 6-benzyl-5,6,7,8-tetrahydro-2 (1
H) -Oxo-1,6-naphthyridine-3-carboxylate ethyl:

【0039】(1)1−ベンジル−4−ピペリドン19
g(0.1モル)とピロリジン10.7g(0.15モ
ル)のトルエン200mlの溶液を、水を留去しながら5
時間加熱還流した。反応溶液を減圧下に濃縮乾固した
後、残渣に無水トルエン200mlを加えた。次いで、氷
冷攪拌下にエトキシメチレンシアノ酢酸エチル17g
(0.1モル)の無水トルエン50mlの溶液をゆっくり
と滴下した。室温に戻し、終夜攪拌した後、氷冷下に濃
塩酸13mlを滴下した。得られた塩酸塩を濾取し、酢酸
エチル、イソプロピルエーテルの順に洗浄した。この塩
酸塩をエタノール300mlに溶かし、氷冷下アンモニア
ガスを吹き込み飽和させた。室温に戻し、終夜放置した
後、溶液を減圧下に濃縮乾固した。残渣にイソプロパノ
ールを加え、析出結晶を濾取、乾燥して粗結晶10gを
得た。
(1) 1-benzyl-4-piperidone 19
A solution of g (0.1 mol) and 10.7 g (0.15 mol) of pyrrolidine in 200 ml of toluene was added while distilling off water.
Heated to reflux for hours. After the reaction solution was concentrated to dryness under reduced pressure, 200 ml of anhydrous toluene was added to the residue. Then, 17 g of ethyl ethoxymethylene cyanoacetate under stirring with ice cooling
A solution of (0.1 mol) in 50 ml of anhydrous toluene was slowly added dropwise. After returning to room temperature and stirring overnight, 13 ml of concentrated hydrochloric acid was added dropwise under ice cooling. The obtained hydrochloride was collected by filtration and washed with ethyl acetate and isopropyl ether in this order. This hydrochloride was dissolved in 300 ml of ethanol, and saturated with ammonia gas blown therein under ice cooling. After returning to room temperature and standing overnight, the solution was concentrated to dryness under reduced pressure. Isopropanol was added to the residue, and the precipitated crystals were collected by filtration and dried to obtain 10 g of crude crystals.

【0040】上記粗結晶をエタノール100mlに溶か
し、氷冷攪拌下10%水酸化ナトリウム水溶液を滴下し
た。室温に戻し、30分間攪拌した後、氷冷下に水10
0mlを加えた。析出結晶を濾取、水洗した後、イソプロ
パノールから再結晶して無色固体の2−アミノ−6−ベ
ンジル−5,6,7,8−テトラヒドロ−1,6−ナフ
チリジン−3−カルボン酸エチル8.5g(収率27.
3%)を得た。融点141〜143℃。
The above crude crystals were dissolved in 100 ml of ethanol, and a 10% aqueous sodium hydroxide solution was added dropwise while stirring with ice cooling. After returning to room temperature and stirring for 30 minutes, water 10 was added under ice cooling.
0 ml was added. The precipitated crystals were collected by filtration, washed with water, and recrystallized from isopropanol to give colorless solid 2-amino-6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carboxylate ethyl ester. 5 g (yield 27.
3%) was obtained. Melting point 141-143 [deg.] C.

【0041】(2)上記エステル10g(32ミリモ
ル)の10%硫酸水溶液100mlの溶液に、氷冷攪拌下
亜硝酸ソーダ4.5g(65ミリモル)の水20mlの水
溶液をゆっくりと滴下した。滴下終了後そのまま2時間
攪拌した。氷冷攪拌下20%水酸化ナトリウム水溶液で
アルカリ性にし、クロロホルムで抽出した。抽出液を無
水硫酸ナトリウムで乾燥した後、溶媒を減圧留去した。
得られた結晶をイソプロパノールから再結晶して無色固
体6.8g(収率68%)を得た。融点168〜170
℃。
(2) To a solution of 10 g (32 mmol) of the above ester in 100 ml of 10% sulfuric acid aqueous solution, an aqueous solution of 4.5 g (65 mmol) of sodium nitrite in 20 ml of water was slowly added dropwise while stirring with ice cooling. After completion of dropping, the mixture was stirred for 2 hours as it was. The mixture was made alkaline with a 20% aqueous sodium hydroxide solution under stirring with ice cooling, and extracted with chloroform. After the extract was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure.
The obtained crystals were recrystallized from isopropanol to obtain 6.8 g (yield 68%) of a colorless solid. Melting point 168-170
° C.

【0042】実施例2: 6−ベンジル−5,6,7,8−テトラヒドロ−2(1
H)−オキソ−1,6−ナフチリジン−3−カルボン酸
・塩酸塩:
Example 2 : 6-benzyl-5,6,7,8-tetrahydro-2 (1
H) -oxo-1,6-naphthyridine-3-carboxylic acid hydrochloride:

【0043】(a)6−ベンジル−5,6,7,8−テ
トラヒドロ−2(1H)−オキソ−1,6−ナフチリジ
ン−3−カルボン酸エチル6.8g(22ミリモル)と
20%塩酸水溶液70mlの溶液を3時間加熱還流した。
冷後、析出結晶を濾取、水洗した。メタノール−水から
再結晶して無色固体の目的物7.0g(収率99.2
%)を得た。融点260〜263℃。
(A) Ethyl 6-benzyl-5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3-carboxylate 6.8 g (22 mmol) and a 20% hydrochloric acid aqueous solution. The 70 ml solution was heated to reflux for 3 hours.
After cooling, the precipitated crystals were collected by filtration and washed with water. Recrystallization from methanol-water yielded 7.0 g of the desired product as a colorless solid (yield 99.2).
%) Was obtained. Melting point 260-263 [deg.] C.

【0044】(b)1−ベンジル−4−ピペリドン10
0g(0.53モル)とピロリジン70ml(0.795
モル)のトルエン1.5Lの溶液を、水を留去しながら
5時間加熱還流した。反応溶液を減圧下に濃縮乾固した
後、残渣にジオキサン1Lを加えた。次いで、氷冷攪拌
下にエトキシメチレンマロン酸ジエチル126g(0.
58モル)を加え、6時間加熱還流した。室温に戻し、
酢酸アンモニウム82g(1.06モル)を加え、80
℃,1時間加熱攪拌した。反応溶液を減圧下に濃縮乾固
した。得られた6−ベンジル−5,6,7,8−テトラ
ヒドロ−2(1H)−オキソ−1,6−ナフチリジン−
3−カルボン酸エチルを単離・精製することなく20%
塩酸水溶液600mlを加え、3時間加熱還流した。冷
後、析出結晶を濾取、水洗した。メタノール−水から再
結晶して無色固体の目的物105g(収率61.9%)
を得た。融点260〜263℃。
(B) 1-benzyl-4-piperidone 10
0 g (0.53 mol) and 70 ml of pyrrolidine (0.795
A solution of 1.5 mol of toluene in 1.5 mol) was heated under reflux for 5 hours while distilling off water. The reaction solution was concentrated to dryness under reduced pressure, and 1 L of dioxane was added to the residue. Then, 126 g of diethyl ethoxymethylenemalonate (0.
(58 mol) was added and the mixture was heated under reflux for 6 hours. Return to room temperature,
82 g (1.06 mol) of ammonium acetate was added,
The mixture was heated and stirred at ℃ for 1 hour. The reaction solution was concentrated to dryness under reduced pressure. The resulting 6-benzyl-5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-
20% without isolation and purification of ethyl 3-carboxylate
600 ml of an aqueous hydrochloric acid solution was added, and the mixture was heated under reflux for 3 hours. After cooling, the precipitated crystals were collected by filtration and washed with water. Recrystallization from methanol-water gave 105 g of the desired product as a colorless solid (yield 61.9%).
Got Melting point 260-263 [deg.] C.

【0045】実施例3: 5,6,7,8−テトラヒドロ−2(1H)−オキソ−
1,6−ナフチリジン−3−カルボン酸エチル・酢酸
塩:
Example 3 : 5,6,7,8-Tetrahydro-2 (1H) -oxo-
Ethyl 1,6-naphthyridine-3-carboxylic acid acetate:

【0046】6−ベンジル−5,6,7,8−テトラヒ
ドロ−2(1H)−オキソ−1,6−ナフチリジン−3
−カルボン酸エチル8gと氷酢酸360mlの溶液に触媒
の10%パラジウム−炭素200mgを加え、水素雰囲気
下室温で接触水素還元した。理論量の水素ガスを吸収し
た後、触媒を濾去し、濾液を減圧下に濃縮乾固した。残
渣にエタノールを加え、結晶を濾取した後、エタノール
−水から再結晶して無色固体6.8g(収率94%)を
得た。融点125〜130℃。
6-benzyl-5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3
-To a solution of 8 g of ethyl carboxylate and 360 ml of glacial acetic acid was added 200 mg of 10% palladium-carbon as a catalyst, and catalytic hydrogen reduction was carried out at room temperature in a hydrogen atmosphere. After absorbing the theoretical amount of hydrogen gas, the catalyst was filtered off and the filtrate was concentrated to dryness under reduced pressure. Ethanol was added to the residue, the crystals were collected by filtration, and then recrystallized from ethanol-water to obtain 6.8 g of a colorless solid (yield 94%). Melting point 125-130 [deg.] C.

【0047】実施例4: 6−(3−フルオロベンジル)−5,6,7,8−テト
ラヒドロ−2(1H)−オキソ−1,6−ナフチリジン
−3−カルボン酸エチル:
Example 4 : Ethyl 6- (3-fluorobenzyl) -5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3-carboxylate:

【0048】5,6,7,8−テトラヒドロ−2(1
H)−オキソ−1,6−ナフチリジン−3−カルボン酸
エチル・酢酸塩2.0g(7.1ミリモル)、臭化3−
フルオロベンジル1.7g(9ミリモル)および重炭酸
ナトリウム2.0g(24ミリモル)のメチルエチルケ
トン100mlの懸濁液を16時間加熱還流した。不溶物
を濾去し、濾液を減圧下に濃縮乾固した。残渣をダイヤ
イオンCHP−20Pを用いた中圧カラムクロマトグラ
フィーに付し、アセトニトリル/水の濃度勾配で溶出・
精製した。エタノールから再結晶し、無色固体1.91
g(収率81.4%)を得た。融点276〜280℃。
5,6,7,8-Tetrahydro-2 (1
H) -Oxo-1,6-naphthyridine-3-carboxylic acid ethyl acetate 2.0 g (7.1 mmol), 3-bromide
A suspension of 1.7 g (9 mmol) of fluorobenzyl and 2.0 g (24 mmol) of sodium bicarbonate in 100 ml of methyl ethyl ketone was heated under reflux for 16 hours. The insoluble material was filtered off, and the filtrate was concentrated to dryness under reduced pressure. The residue was subjected to medium pressure column chromatography using Diaion CHP-20P and eluted with a concentration gradient of acetonitrile / water.
Purified. Recrystallized from ethanol, colorless solid 1.91
g (yield 81.4%) was obtained. Melting point 276-280 [deg.] C.

【0049】実施例5: 6−(2−フルオロベンジル)−5,6,7,8−テト
ラヒドロ−2(1H)−オキソ−1,6−ナフチリジン
−3−カルボン酸・塩酸塩:
Example 5 : 6- (2-Fluorobenzyl) -5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3-carboxylic acid hydrochloride:

【0050】(1)二塩化フェニルホスホン酸1mlに室
温下6−ベンジル−5,6,7,8−テトラヒドロ−2
(1H)−オキソ−1,6−ナフチリジン−3−カルボ
ン酸エチル1.0g(3.2ミリモル)を加えた後、1
50℃,1時間攪拌した。冷後、ジイソプロピルエーテ
ルを加え、結晶を濾取した。この結晶をクロロホルムに
懸濁し、氷冷攪拌下28%アンモニア水を少しずつ加え
てアルカリ性にした。有機層を分取し、無水硫酸ナトリ
ウムで乾燥した後、溶媒を減圧留去した。得られた油状
物をシリカゲルカラムクロマトグラフィーに付し、クロ
ロホルム−メタノール(200:1)で溶出・精製して
6−ベンジル−2−クロロ−5,6,7,8−テトラヒ
ドロ−1,6−ナフチリジン−3−カルボン酸エチル
0.7g(収率66.1%)を無色油状物として得た。
(1) To 1 ml of phenylphosphonic acid dichloride at room temperature was added 6-benzyl-5,6,7,8-tetrahydro-2.
After adding 1.0 g (3.2 mmol) of ethyl (1H) -oxo-1,6-naphthyridine-3-carboxylate, 1
The mixture was stirred at 50 ° C for 1 hour. After cooling, diisopropyl ether was added and the crystals were collected by filtration. The crystals were suspended in chloroform, and 28% aqueous ammonia was added little by little under ice-cooling stirring to make the mixture alkaline. The organic layer was separated and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained oily substance was subjected to silica gel column chromatography, and eluted and purified with chloroform-methanol (200: 1) to give 6-benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-. 0.7 g (yield 66.1%) of ethyl naphthyridine-3-carboxylate was obtained as a colorless oil.

【0051】(2)上記エステル20.0g(60ミリ
モル)の塩化メチレン200mlの溶液に、クロロ炭酸
(1−クロロエチル)10.4g(72ミリモル)を室
温で滴下し、20時間攪拌した。次いで、反応溶液を減
圧下に濃縮乾固した後、残渣にメタノール200mlを加
え、40℃,2時間加熱攪拌した。反応溶液を減圧下に
濃縮乾固した後、残渣にジイソプロピルエーテルを加え
結晶を濾取した。エタノールから再結晶し、無色固体の
2−クロロ−5,6,7,8−テトラヒドロ−1,6−
ナフチリジン−3−カルボン酸エチル・塩酸塩21.2
g(収率85.8%)を得た。融点153〜156℃。
(2) To a solution of 20.0 g (60 mmol) of the above ester in 200 ml of methylene chloride, 10.4 g (72 mmol) of chlorocarbonic acid (1-chloroethyl) was added dropwise at room temperature and stirred for 20 hours. Next, the reaction solution was concentrated to dryness under reduced pressure, 200 ml of methanol was added to the residue, and the mixture was heated and stirred at 40 ° C. for 2 hours. The reaction solution was concentrated to dryness under reduced pressure, diisopropyl ether was added to the residue, and the crystals were collected by filtration. Recrystallization from ethanol gave colorless solid 2-chloro-5,6,7,8-tetrahydro-1,6-
Naphthyridine-3-carboxylate ethyl hydrochloride 21.2
g (yield 85.8%) was obtained. Melting point 153-156 [deg.] C.

【0052】(3)上記塩酸塩5.0g(18ミリモ
ル)、トリエチルアミン4.0g(40ミリモル)のD
MF50mlの溶液に、臭化2−フルオロベンジル3.1
g(21ミリモル)を加え、60℃,15時間加熱攪拌
した。反応溶液を減圧下に濃縮乾固した。残渣をクロロ
ホルムに溶かし、10%炭酸カリウム水溶液、水の順で
洗浄した。有機層を無水硫酸ナトリウムで乾燥した後、
溶媒を減圧留去した。得られた油状物をシリカゲルカラ
ムクロマトグラフィーに付し、クロロホルム−メタノー
ル(100:1)で溶出・精製して2−クロロ−6−
(2−フルオロベンジル)−5,6,7,8−テトラヒ
ドロ−1,6−ナフチリジン−3−カルボン酸エチル
4.6g(収率73.3%)を無色油状物として得た。
(3) 5.0 g (18 mmol) of the above hydrochloride and 4.0 g (40 mmol) of triethylamine
2-Fluorobenzyl bromide 3.1 in a solution of 50 ml MF.
g (21 mmol) was added, and the mixture was heated with stirring at 60 ° C. for 15 hours. The reaction solution was concentrated to dryness under reduced pressure. The residue was dissolved in chloroform and washed with 10% aqueous potassium carbonate solution and water in this order. After drying the organic layer with anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure. The obtained oily substance was subjected to silica gel column chromatography, and eluted and purified with chloroform-methanol (100: 1) to give 2-chloro-6-.
Ethyl (2-fluorobenzyl) -5,6,7,8-tetrahydro-1,6-naphthyridine-3-carboxylate (4.6 g, yield 73.3%) was obtained as a colorless oil.

【0053】(4)上記エステル4.6g(13ミリモ
ル)と20%塩酸水溶液80mlの溶液を24時間加熱還
流した。氷冷した後、析出結晶を濾取、水洗した。エタ
ノールから再結晶して無色固体の目的物3.4g(収率
77.2%)を得た。融点273〜276℃。
(4) A solution of 4.6 g (13 mmol) of the above ester and 80 ml of 20% aqueous hydrochloric acid was heated under reflux for 24 hours. After cooling with ice, the precipitated crystals were collected by filtration and washed with water. Recrystallization from ethanol gave 3.4 g (yield 77.2%) of the desired product as a colorless solid. Melting point 273-276 [deg.] C.

【0054】対応する原料化合物を用い、実施例5
(3),(4)と同様に反応・処理し、表1〜3に掲載
の実施例6〜52の化合物を得た。
Example 5 using the corresponding starting compounds
Reaction and treatment were carried out in the same manner as (3) and (4) to obtain the compounds of Examples 6 to 52 listed in Tables 1 to 3.

【0055】[0055]

【表1】 [Table 1]

【0056】[0056]

【表2】 [Table 2]

【0057】[0057]

【表3】 [Table 3]

【0058】参考例1: 6−ベンジル−3−(5−メトキシ−1,3,4−オキ
サジアゾール−2−イル)−5,6,7,8−テトラヒ
ドロ−1,6−ナフチリジン−2(1H)−オンの製
造:
Reference Example 1 : 6-benzyl-3- (5-methoxy-1,3,4-oxadiazol-2-yl) -5,6,7,8-tetrahydro-1,6-naphthyridine-2 Production of (1H) -one:

【0059】(1)6−ベンジル−5,6,7,8−テ
トラヒドロ−2(1H)−オキソ−1,6−ナフチリジ
ン−3−カルボン酸・塩酸塩3.0g(9.4ミリモ
ル)とN,N’−カルボニルジイミダゾール2.3g
(14ミリモル)のN,N−ジメチルホルムアミド(D
MF)50mlの溶液を70℃,3時間加熱攪拌した。次
いで、この溶液にカルバジン酸メチル1.0g(11ミ
リモル)を加え、同温度で2時間加熱攪拌した。反応溶
液を減圧下に濃縮乾固し、残渣にイソプロパノールおよ
びトリエチルアミンを加えた。析出結晶を濾取し、メタ
ノールから再結晶して無色固体のN’−メトキシカルボ
ニル−6−ベンジル−5,6,7,8−テトラヒドロ−
2(1H)−オキソ−1,6−ナフチリジン−3−カル
ボヒドラジド2.4g(収率71.6%)を得た。融点
240〜242℃。
(1) 3.0 g (9.4 mmol) of 6-benzyl-5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3-carboxylic acid / hydrochloride. 2.3 g of N, N'-carbonyldiimidazole
(14 mmol) N, N-dimethylformamide (D
A solution of 50 ml of MF) was heated and stirred at 70 ° C. for 3 hours. Next, 1.0 g (11 mmol) of methyl carbazate was added to this solution, and the mixture was heated with stirring at the same temperature for 2 hours. The reaction solution was concentrated to dryness under reduced pressure, and isopropanol and triethylamine were added to the residue. The precipitated crystals were collected by filtration and recrystallized from methanol to give N'-methoxycarbonyl-6-benzyl-5,6,7,8-tetrahydro- as a colorless solid.
2.4 g (71.6% yield) of 2 (1H) -oxo-1,6-naphthyridine-3-carbohydrazide was obtained. Melting point 240-242 [deg.] C.

【0060】(2)上記化合物2.0g(5.6ミリモ
ル)、トリフェニルホスフィン3.0g(11ミリモ
ル)およびトリエチルアミン2.0g(20ミリモル)
の無水テトラヒドロフラン(THF)50mlの溶液に、
氷冷攪拌下アゾジカルボン酸ジイソプロピル2.2g
(11ミリモル)の無水THF10mlの溶液を滴下し
た。室温で1時間攪拌した後、少量の水を加えて減圧下
に濃縮乾固した。残渣にイソプロパノールを加え、析出
結晶を濾取し、アセトニトリルから再結晶して無色固体
0.8g(収率43%)を得た。融点176〜178
℃。(収率44.8%)を得た。融点221〜223
℃。
(2) 2.0 g (5.6 mmol) of the above compound, 3.0 g (11 mmol) of triphenylphosphine and 2.0 g (20 mmol) of triethylamine.
In 50 ml of anhydrous tetrahydrofuran (THF),
2.2 g of diisopropyl azodicarboxylate with stirring under ice cooling
A solution of (11 mmol) in 10 ml of anhydrous THF was added dropwise. After stirring at room temperature for 1 hour, a small amount of water was added and the mixture was concentrated to dryness under reduced pressure. Isopropanol was added to the residue, and the precipitated crystals were collected by filtration and recrystallized from acetonitrile to obtain 0.8 g of a colorless solid (yield 43%). Melting point 176-178
° C. (Yield 44.8%) was obtained. Melting point 221-223
° C.

【0061】薬理:参考例1の化合物はベンゾジアゼピ
ン受容体に対して顕著な親和性を示し、また、マウスを
用いたペンチレンテトラゾール誘発間代性痙攣に対して
優れた拮抗作用を示すので、ベンゾジアゼピン受容体作
動薬、例えば、抗不安薬、抗てんかん薬あるいは睡眠障
害の治療薬として有用である。
Pharmacology : The compound of Reference Example 1 has a marked affinity for the benzodiazepine receptor and an excellent antagonism against pentylenetetrazole-induced clonic convulsion in mice. It is useful as a receptor agonist, for example, an anxiolytic drug, an antiepileptic drug, or a therapeutic drug for sleep disorders.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 古川 清 滋賀県滋賀郡志賀町小野水明2丁目12番地 4号 (72)発明者 岡 眞 大阪府茨木市高田町17番26号 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Kiyoshi Furukawa 2-12-12, Onomizumei, Shiga-cho, Shiga-gun, Shiga Prefecture (72) Inventor Makoto Oka 17-26 Takada-cho, Ibaraki-shi, Osaka

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 下記式 【化1】 (式中、R1 は水素原子,アシル基,低級アルキル基ま
たはR1'CH2-を意味し、R1'はシクロ低級アルキル
基, 低級アルケニル基, 低級アルキニル基, ベンジル
基, アリール基または芳香族複素環基を意味し、Rは水
素原子,低級アルキル基またはベンジル基を意味する。
但し、R1 はメチル基でない。)で表される5,6,
7,8−テトラヒドロ−2(1H)−1,6−ナフチリ
ジン−3−カルボン酸誘導体またはその塩。
1. The following formula: (In the formula, R 1 represents a hydrogen atom, an acyl group, a lower alkyl group or R 1 'CH 2- , and R 1 ' is a cyclo lower alkyl group, a lower alkenyl group, a lower alkynyl group, a benzyl group, an aryl group or It means an aromatic heterocyclic group, and R means a hydrogen atom, a lower alkyl group or a benzyl group.
However, R 1 is not a methyl group. ), 5, 6,
A 7,8-tetrahydro-2 (1H) -1,6-naphthyridine-3-carboxylic acid derivative or a salt thereof.
【請求項2】 R1 がR1'CH2-であって、R1'がフェ
ニル基または1乃至2個のハロゲン原子で置換されたフ
ェニル基である請求項1記載の化合物またはその塩。
2. The compound according to claim 1, wherein R 1 is R 1 ′ CH 2 —, and R 1 ′ is a phenyl group or a phenyl group substituted with 1 to 2 halogen atoms, or a salt thereof.
【請求項3】 6−ベンジル−5,6,7,8−テトラ
ヒドロ−2(1H)−オキソ−1,6−ナフチリジン−
3−カルボン酸、6−(2−クロロベンジル)−5,
6,7,8−テトラヒドロ−2(1H)−オキソ−1,
6−ナフチリジン−3−カルボン酸、6−(4−クロロ
ベンジル)−5,6,7,8−テトラヒドロ−2(1
H)−オキソ−1,6−ナフチリジン−3−カルボン
酸、6−(2−ブロモベンジル)−5,6,7,8−テ
トラヒドロ−2(1H)−オキソ−1,6−ナフチリジ
ン−3−カルボン酸、6−(2−クロロ−5−フルオロ
ベンジル)−5,6,7,8−テトラヒドロ−2(1
H)−オキソ−1,6−ナフチリジン−3−カルボン
酸、および6−(2−ブロモ−5−フルオロベンジル)
−5,6,7,8−テトラヒドロ−2(1H)−オキソ
−1,6−ナフチリジン−3−カルボン酸から選ばれる
いずれか1つの化合物またはその塩。
3. 6-Benzyl-5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-
3-carboxylic acid, 6- (2-chlorobenzyl) -5,
6,7,8-tetrahydro-2 (1H) -oxo-1,
6-naphthyridine-3-carboxylic acid, 6- (4-chlorobenzyl) -5,6,7,8-tetrahydro-2 (1
H) -oxo-1,6-naphthyridine-3-carboxylic acid, 6- (2-bromobenzyl) -5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3- Carboxylic acid, 6- (2-chloro-5-fluorobenzyl) -5,6,7,8-tetrahydro-2 (1
H) -oxo-1,6-naphthyridine-3-carboxylic acid, and 6- (2-bromo-5-fluorobenzyl)
Any one compound selected from -5,6,7,8-tetrahydro-2 (1H) -oxo-1,6-naphthyridine-3-carboxylic acid or a salt thereof.
JP7037649A 1992-09-02 1995-02-01 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt Pending JPH07252255A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7037649A JPH07252255A (en) 1992-09-02 1995-02-01 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26079692 1992-09-02
JP4-260796 1992-09-02
JP7037649A JPH07252255A (en) 1992-09-02 1995-02-01 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP5240599A Division JP2673654B2 (en) 1992-09-02 1993-08-31 Tetrahydro-1,6-naphthyridine derivative and salt thereof

Publications (1)

Publication Number Publication Date
JPH07252255A true JPH07252255A (en) 1995-10-03

Family

ID=17352866

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5240599A Expired - Lifetime JP2673654B2 (en) 1992-09-02 1993-08-31 Tetrahydro-1,6-naphthyridine derivative and salt thereof
JP7037649A Pending JPH07252255A (en) 1992-09-02 1995-02-01 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP5240599A Expired - Lifetime JP2673654B2 (en) 1992-09-02 1993-08-31 Tetrahydro-1,6-naphthyridine derivative and salt thereof

Country Status (2)

Country Link
JP (2) JP2673654B2 (en)
ZA (1) ZA936048B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241379A (en) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd 3-oxadiazolylquinoxaline derivative
JP4049297B2 (en) 2001-06-11 2008-02-20 株式会社ルネサステクノロジ Semiconductor memory device

Also Published As

Publication number Publication date
ZA936048B (en) 1994-03-15
JPH06192258A (en) 1994-07-12
JP2673654B2 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
CA2172472C (en) Pyrido[3,2-e]pyrazinones with anti-asthmatic action and processes for their manufacture
CA2211669A1 (en) 6-substituted pyrazolo [3,4-d¦ pyrimidin-4-ones and compositions and methods of use thereof
FR2563521A1 (en) 1,4-DIHYDRO-4-OXONAPHTYRIDINE DERIVATIVES AND THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND ANTIBACTERIAL AGENTS CONTAINING SAME
EP0104522B1 (en) New pyrazolo(3,4-b)pyridine derivatives and process for producing them
JP2753659B2 (en) Pyrazole derivatives
JP2740250B2 (en) Hetera-aliphatic carboxamide derivative, method for producing the same, intermediate of the compound, and pharmaceutical composition containing leukotriene antagonism containing the compound
EP0874849B1 (en) 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
HU197749B (en) Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient
JPH04273878A (en) Heterocyclic compound and preparation thereof
EP1023291B1 (en) Dipyridoimidazolderivatives useful in treating central nervous system disorders
WO1995021836A1 (en) 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
PL196778B1 (en) Chemical synthesis of morpholine derivatives
JPH07252255A (en) 5,6,7,8-tetrahydro-2(1h-oxo-1,6-naphthyridine-3-carboxylic acid production and its salt
RU2147303C1 (en) Intermediates and method of preparing naphthiridone carboxylic acid salts
JP2997828B2 (en) Quinoline and naphthyridine derivatives
JPH08503224A (en) New production method of β-carboline
JP3479708B2 (en) Benzoic acid derivative
CZ180793A3 (en) Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
US5302722A (en) 3-carboxy-pyrrole derivatives
EP1299389A1 (en) A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
AU2001258896A1 (en) A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
JPH09104684A (en) 5,6,7,8-tetrahydro-2(1h)-oxo-1,6-naphthyridine-3-carbonitrile derivative and its acid addition salt
EP1009748A1 (en) 3-ALKYLPYRROLO 3,2-$i(c)]QUINOLINE DERIVATIVES
US5929240A (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US5484924A (en) Imidazonaphthyridine derivatives